Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.

Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Abstract Text:

    iwona Iwona ,maria mosorMaria Mosor,malgorzata wierzbickaMalgorzata Wierzbicka,malgorzata rydzaniczMalgorzata Rydzanicz,monika pernak-schwarzMonika Pernak-Schwarz,jerzy nowakJerzy Nowak,iwona Iwona ,maria mosorMaria Mosor,malgorzata wierzbickaMalgorzata Wierzbicka,malgorzata rydzaniczMalgorzata Rydzanicz,monika pernak-schwarzMonika Pernak-Schwarz,jerzy nowakJerzy Nowak,

    The high incidence of multiple primary tumors (MPT) is a significant problem in head and neck tumor treatment. Recent studies suggest that carriers of heterozygous mutations in the NBS1 gene have an increased risk of malignant tumor development. The aim of our research was to assess the frequency of NBS1 mutations in patients with larynx cancer only (LC) and with MPT. The MPT group consisted of patients with one cancer localized to the larynx (primary or second) and another at another site. DNA from 175 patients with LC and 93 patients with MPT was analyzed using the single-strand conformation polymorphism method and direct sequencing. We found nine carriers of the I171V mutation among these 268 cancer patients and only one carrier among 500 population controls (0.2%). Four carriers of the I171V mutation were detected among 175 LC patients (2.3%) and five among 93 patients with MPT (5.4%). The frequencies of the I171V mutation carriers in LC and MPT patients were significantly higher than in controls (odds ratio [OR] = 11.7, confidence interval [CI] 1.3-105.2, P = 0.0175 and OR = 28.35, CI 3.27-245.7, P = 0.0005, respectively). In one individual with LC, a novel molecular variant, c.1222 A > G (p.K408E), was identified. No carriers of R215W or 657del5 NBS1 mutations were found in the present study. These findings imply that heterozygous carriers of the I171V mutation are prone to the development of larynx cancer and may, in addition, display an increased risk of second tumors at other sites.

    Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Publishing Authors By Initials

    i I ,m mosorM Mosor,m wierzbickaM Wierzbicka,m rydzaniczM Rydzanicz,m pernak-schwarzM Pernak-Schwarz,j nowakJ Nowak,i I ,m mosorM Mosor,m wierzbickaM Wierzbicka,m rydzaniczM Rydzanicz,m pernak-schwarzM Pernak-Schwarz,j nowakJ Nowak,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Cancer science

    VOLUME: 98

    Page Numbers: 1701-5

    Journal Abbreviation: Cancer Sci.

    ISSN: 1349-7006

    DAY: 26

    MONTH: Nov

    YEAR: 2007

    Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101168776

    Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene.

    AFFILIATION: Department of Molecular Pathology, Institute of Human Genetics, Polish Academy of Sciences, Strzeszyńska St 32, Poznan 60-479, Poland. iwonus21@wp.pl

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News